107 related articles for article (PubMed ID: 29921500)
21. Serum Actinin-4 Levels as a Potential Diagnostic and Prognostic Marker in Cervical Cancer.
Ma X; Xue H; Zhong J; Feng B; Zuo Y
Dis Markers; 2020; 2020():5327378. PubMed ID: 32855746
[TBL] [Abstract][Full Text] [Related]
22. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
[TBL] [Abstract][Full Text] [Related]
23. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer.
Bibok A; Kim DW; Malafa M; Kis B
World J Gastroenterol; 2021 Jul; 27(27):4322-4341. PubMed ID: 34366607
[TBL] [Abstract][Full Text] [Related]
24. Clinical usefulness of ¹⁸F-fluorodeoxyglucose-positron emission tomography in patients with locally advanced pancreatic cancer planned to undergo concurrent chemoradiation therapy.
Chang JS; Choi SH; Lee Y; Kim KH; Park JY; Song SY; Cho A; Yun M; Lee JD; Seong J
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):126-33. PubMed ID: 25015206
[TBL] [Abstract][Full Text] [Related]
25. The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer.
Honda K
Cell Biosci; 2015; 5():41. PubMed ID: 26288717
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection.
Huguet F; Hajj C; Winston CB; Shi W; Zhang Z; Wu AJ; O'Reilly EM; Reidy DL; Allen P; Goodman KA
Acta Oncol; 2017 Mar; 56(3):384-390. PubMed ID: 27796165
[TBL] [Abstract][Full Text] [Related]
27. Role of ACTN4 in Tumorigenesis, Metastasis, and EMT.
Tentler D; Lomert E; Novitskaya K; Barlev NA
Cells; 2019 Nov; 8(11):. PubMed ID: 31766144
[TBL] [Abstract][Full Text] [Related]
28. Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation.
Krishnan S; Chadha AS; Suh Y; Chen HC; Rao A; Das P; Minsky BD; Mahmood U; Delclos ME; Sawakuchi GO; Beddar S; Katz MH; Fleming JB; Javle MM; Varadhachary GR; Wolff RA; Crane CH
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):755-65. PubMed ID: 26972648
[TBL] [Abstract][Full Text] [Related]
29. [Chemoradiotherapy for Locally Advanced Pancreatic Cancer].
Okano N; Kawai K; Naruge D; Kitamura H; Nagashima F; Furuse J
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1152-5. PubMed ID: 26489544
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy.
Månsson C; Brahmstaedt R; Nilsson A; Nygren P; Karlson BM
Eur J Surg Oncol; 2016 Sep; 42(9):1401-6. PubMed ID: 26906114
[TBL] [Abstract][Full Text] [Related]
31. Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.
Stein SM; James ES; Deng Y; Cong X; Kortmansky JS; Li J; Staugaard C; Indukala D; Boustani AM; Patel V; Cha CH; Salem RR; Chang B; Hochster HS; Lacy J
Br J Cancer; 2016 Mar; 114(7):737-43. PubMed ID: 27022826
[TBL] [Abstract][Full Text] [Related]
32. Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review.
Huguet F; Girard N; Guerche CS; Hennequin C; Mornex F; Azria D
J Clin Oncol; 2009 May; 27(13):2269-77. PubMed ID: 19307501
[TBL] [Abstract][Full Text] [Related]
33. Nontrial, real-world outcomes in unresectable locally advanced pancreatic cancer: Chemotherapy and chemoradiation is the standard while surgery is uncommon.
Ramaswamy A; Jandyal S; Ostwal V; Engineer R; Lewis S; Bose S; Pande N; Shrikhande SV
Indian J Cancer; 2017; 54(3):530-534. PubMed ID: 29798952
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.
Chen X; Liu G; Wang K; Chen G; Sun J
Oncotarget; 2017 Jul; 8(29):47831-47840. PubMed ID: 28599299
[TBL] [Abstract][Full Text] [Related]
35. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer.
Chadha AS; Kocak-Uzel E; Das P; Minsky BD; Delclos ME; Mahmood U; Guha S; Ahmad M; Varadhachary GR; Javle M; Katz MH; Fleming JB; Wolff RA; Crane CH; Krishnan S
Acta Oncol; 2015 Jul; 54(7):971-8. PubMed ID: 25608822
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer.
Jackson AS; Jain P; Watkins GR; Whitfield GA; Green MM; Valle J; Taylor MB; Dickinson C; Price PM; Saleem A
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):570-7. PubMed ID: 20650619
[TBL] [Abstract][Full Text] [Related]
37. Patterns of Care for Locally Advanced Pancreatic Adenocarcinoma Using the National Cancer Database.
Amini A; Jones BL; Stumpf P; Leong S; Lieu CH; Weekes C; Davis SL; Messersmith WA; Purcell WT; Ghosh D; Schefter T; Goodman KA
Pancreas; 2017 Aug; 46(7):904-912. PubMed ID: 28697131
[TBL] [Abstract][Full Text] [Related]
38. Ablation treatments in unresectable pancreatic cancer.
Paiella S; De Pastena M; Romeo F; D'onofrio M; Fontana M; Pea A; De Marchi G; Crinò SF; Bassi C; Salvia R
Minerva Chir; 2019 Jun; 74(3):263-269. PubMed ID: 30600963
[TBL] [Abstract][Full Text] [Related]
39. Multi-disciplinary management of locally advanced pancreatic cancer with irreversible electroporation.
Martin RCG
J Surg Oncol; 2017 Jul; 116(1):35-45. PubMed ID: 28475814
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
